Cognitive impairment in chronic kidney disease

Journal of the American Geriatrics Society

Volumn 52, Issue 11, 2004, Pages 1863-1869

  Kurella, Manjula ^a   Chertow, Glenn M ^a   Luan, Jennifer ^a   Yaffe, Kristine ^a,b  

^a UCSF Medical Center at Parnassus   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease; Cognitive impairment; Dementia; End stage renal disease

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR; ANALYSIS OF VARIANCE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; UNITED STATES;

ANALYSIS OF VARIANCE; CALIFORNIA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 16544390383     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52508.x     Document Type: Article

References (36)

1. U.S. Renal Data System: Excerpts from the USRDS 2002 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003;41:51-5260.
2. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
3. Graham JE, Rockwood K, Beattie BL et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
4. Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population. The Hisayama Study. Neurology 1995;45:1161-1168.
5. Ott A, Stolk RP, Hofman A et al. Association of diabetes mellitus and dementia. The Rotterdam Study. Diabetologia 1996;39:1392-1397.
6. Yaffe K, Barrett-Connor E, Lin F et al. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002;59:378-384.
7. Souheaver GT, Ryan JJ, DeWolfe AS. Neuropsychological patterns in uremia. J Clin Psychol 1982;38:490-496.
8. Hart RP, Pederson JA, Czerwinski AW et al. Chronic renal failure, dialysis, and neuropsychological function. J Clin Neuropsychol 1983;5:301-312.
9. Teschan PE, Bourne JR, Reed RB et al. Electrophysiological and neurobehavioral responses to therapy: The National Cooperative Dialysis Study. Kidney Int Suppl 1983;April:S58-S65.
10. Pliskin NH, Yurk HM, Ho LT et al. Neurocognitive function in chronic hemodialysis patients. Kidney Int 1996;49:1435-1440.
11. Wolcott DL, Wellisch DK, Marsh JT et al. Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis 1988;12:275-284.
12. Churchill DN, Bird DR, Taylor DW et al. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol 1992;12:412-418.
13. Umans JG, Pliskin NH. Attention and mental processing speed in hemodialysis patients. Am J Kidney Dis 1998;32:749-751.
14. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
15. Yeudall LT, Reddon JR, Gill DM et al. Normative data for the Halstead-Reitan neuropsychological tests stratified by age and sex. J Clin Psychol 1987;43:346-367.
16. Delis D, Kramer J, Kaplan E et al. CVLT-II, 2nd Ed., Adult Version Manual. New York: Psychological Corporation, 2000.
17. Rao S, Carter WB, Mapes DL et al. Development of subscales from the symptoms/problems and effects of kidney disease scales of the kidney disease quality of life instrument. Clin Ther 2000;22:1099-1111.
18. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol 1995;52:612-619.
19. Haan MN, Shemanski L, Jagust WJ et al. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-46.
20. Bornstein RA. Normative data on selected neuropsychological measures from a nonclinical sample. J Clin Psychol 1985;41:651-659.
21. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
22. Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: A comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991;4:173-178.
23. Slatopolsky E, Finch J, Clay P et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-761.
24. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
25. Sehgal AR, Grey SF, DeOreo PB et al. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 1997;30:41-49.
26. Wilson RS, Barnes LL, Mendes de Leon CF et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-370.
27. Wanner C, Zimmermann J, Quaschning T et al. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int Suppl 1997;62:S53-S55.
28. Mallamaci F, Zoccali C, Tripepi G et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002;61:609-614.
29. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003;107:87-92.
30. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
31. Yaffe K, Lindquist K, Penninx BW et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003;61:76-80.
32. Grimm G, Stockenhuber F, Schneeweiss B et al. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 1990;38:480-486.
33. Marsh JT, Brown WS, Wolcott D et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 1991;39:155-163.
34. Seliger SL, Gillen DL, Longstreth WT Jr et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003;64:603-609.
35. Lewis EG, O'Neill WM, Dustman RE et al. Temporal effects of hemodialysis on measures of neural efficiency. Kidney Int 1980;17:357-363.
36. Ratner DP, Adams KM, Levin NW et al. Effects of hemodialysis on the cognitive and sensory-motor functioning of the adult chronic hemodialysis patient. J Behav Med 1983;6:291-311.